Showing 3,841 - 3,860 results of 18,079 for search 'significantly ((((((we decrease) OR (a decrease))) OR (teer decrease))) OR (larger decrease))', query time: 0.47s Refine Results
  1. 3841

    Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  2. 3842

    Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF by Yingzi He (12259307)

    Published 2025
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  3. 3843

    Image3_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  4. 3844

    Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  5. 3845

    Image3_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2025
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  6. 3846

    Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  7. 3847

    Table1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.PDF by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  8. 3848

    Image1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  9. 3849

    Image1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  10. 3850

    Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  11. 3851

    Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2025
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  12. 3852

    Image2_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  13. 3853

    Image1_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2025
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  14. 3854

    Image3_RETRACTED: Effect of histone deacetylase inhibitors trichostatin A and valproic acid on hair cell regeneration in zebrafish lateral line neuromasts.JPEG by Yingzi He (12259307)

    Published 2024
    “…Additionally, BrdU immunostaining and western blot analysis showed that TSA or VPA treatment caused a significant decrease in the percentage of S-phase cells and induced p21<sup>Cip1</sup> and p27<sup>Kip1</sup> expression, both of which are likely to explain the decrease in the amount of newly regenerated hair cells in treated embryos. …”
  15. 3855
  16. 3856

    S1 Data - by Jessica C. M. Hui (20370522)

    Published 2024
    “…Compared to the SD, the HFD and SDG models exhibited significantly increased and decreased contraction velocities and could be used as models of diarrhoea and constipation in DM, respectively, while the ED model showed comparatively little change in motility. …”
  17. 3857

    Specifications of prototypes of RSSCA system. by Ngoc-Hai Vu (22290844)

    Published 2025
    “…Compared to conventional PV systems, the RSSCA offers improved light uniformity, better land-use efficiency, and significantly higher electricity generation. However, in regions with limited direct sunlight, such as Seoul in winter, system performance decreases. …”
  18. 3858

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
  19. 3859

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
  20. 3860

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”